Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Jing Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-7787-7501; OpenAlex author ID A5115595941. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 2 papers · 2025: none · 2026: 1 paper

Papers 3

  1. Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor Mic… Co-author DOI 10.1002/advs.202523985↗
  2. The diagnostic value of combining preoperative serum CA19-9, ALBI score, and 18 F-FDG PET/CT imaging in preoperative resectability of pancreatic cancer. Last author DOI 10.1097/mnm.0000000000001910↗
  3. Combined Therapy of Chemotherapy and Radiofrequency Ablation for Pancreatic Cancer Patients With Metachronous Hepatic Metastatic Lesions After Radical Pancreat… Co-author DOI 10.1177/10732748241274559↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shu‐Li Yang · 1 shared paper, 2024 · strength 0.36
  2. Weirong Lu · 1 shared paper, 2024 · strength 0.31
  3. Lantian Wang · 1 shared paper, 2024 · strength 0.31
  4. Xianlin Han · 1 shared paper, 2026 · strength 0.24
  5. Huanwen Wu · 1 shared paper, 2026 · strength 0.24
  6. Huadan Xue · 1 shared paper, 2026 · strength 0.24
  7. Cheng Si-Hang · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.